Search Results

Displaying Results 3851-3875 of 20633 "'R'"

Jul 14, 2026, 10:31 ET Alport Syndrome Market to Grow at a Tremendous 47% CAGR Through 2036, Driven by Emerging Therapies and Expanding Clinical Pipeline | DelveInsight

(VANRAFIA) [Novartis (Chinook Therapeutics)], Sparsentan (FILSPARI) (Travere Therapeutics and Renalys Pharma), VAR 200 (ZyVersa Therapeutics), R3R01 (River 3 Renal and Bain Capital Life Sciences), and others.Download the report to understand the top emerging Alport syndrome gene

More news about: DelveInsight Business Research, LLP


Jul 14, 2026, 10:23 ET Republic of Honduras Announces Offer to Purchase Existing Notes

Rule 144A Common Code: 155344334Regulation S CUSIP: P5178R AC2Regulation S ISIN: USP5178RAC27Regulation

More news about: Republic of Honduras


Jul 14, 2026, 10:07 ET MSFT Shareholder Alert: August 11, 2026 Lead Plaintiff Deadline in Microsoft Corporation Securities Class Action - Contact The Gross Law Firm

its profitable Azure services in order to improve the competitive positioning of its critical Copilot family of products and increase its AI-related R&D; and (d) as a result of (a)-(c) above, Microsoft had failed to convert a significant percentage of its commercial Microsoft 365 users to paid Copilot

More news about: The Gross Law Firm


Jul 14, 2026, 10:00 ET Nabsys Announces New 30,000-Square-Foot Headquarters in Providence, Rhode Island

innovation districtꟷ  Company will relocate its headquarters in July 2027, bringing manufacturing, technology development, R&D, and G&A together under one roofꟷ  Expansion supported by Rhode Island's life sciences ecosystem and state economic

More news about: Nabsys


Jul 14, 2026, 10:00 ET CNA Financial to Report Second Quarter 2026 Results on August 3

remarks, which will include commentary from the Company's Chairman and Chief Executive Officer, Douglas M. Worman, and Chief Financial Officer, Scott R. Lindquist.CNA invites shareholders and analysts to submit questions for management in advance of the earnings release.

More news about: CNA Financial


Jul 14, 2026, 10:00 ET BRINC Raises $125M to Put a 911 Response Drone on Every Police and Fire Station Roof

public safety. The company builds a connected ecosystem of tools designed to save lives. BRINC manufactures its products in the US, has co-located R&D and production, and is vertically integrated, controlling the entirety of its supply chain. Over 900 public safety agencies and 20%+ of the SWAT teams

More news about: BRINC


Jul 14, 2026, 10:00 ET ImmunoBrain Announces Nature Medicine Publication and Late-Breaking AAIC 2026 Presentation for IBC-Ab002 in Early Alzheimer's Disease

reported in this press release was supported in part by the National Institute on Aging of the National Institutes of Health under Award Number R01AG071810. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.IR

More news about: ImmunoBrain Checkpoint Inc.


Jul 14, 2026, 09:55 ET /C O R R E C T I O N -- ePointZero/

More news about: ePointZero


Jul 14, 2026, 09:46 ET BOMA International TOBYs Award Winning Properties Honored in Long Beach

Equities.In the Historical Building category, the winner is The Chicago Board of Trade Building in Chicago, Illinois. The property is managed by R2 Companies and owned by Apollo Global Management, LLC.In the Industrial Building category, the winner is Transport Depot in Edmonton, Alberta,

More news about: Building Owners and Managers Association International


Jul 14, 2026, 09:00 ET Rayence Launches 'SHINE,' a Next-Generation X-ray Image Processing Technology for Low Dose Imaging

More Than Doubles Signal-to-Noise in Static X-ray ImagingAccording to internal benchmark testing conducted by the Rayence R&D Center under standard radiographic exposure parameters (tube voltage of 74 kVp and a source-to-image distance (SID) of 150 cm), the Signal-to-Noise

More news about: Rayence


Jul 14, 2026, 09:00 ET Delta Electronics (Americas) and X LABS Sign Technology Partnership MOU to Power Next-Gen AI Data Centers

Inc. (TWSE: 2308), a global leader in power management and smart green solutions. We have operated in the Americas for almost 40 years, with offices, R&D centers, manufacturing, and service facilities across the U.S., Canada, Mexico, Brazil, and more. Our smart, energy-saving solutions serve customers

More news about: Delta Electronics (Americas)


Jul 14, 2026, 09:00 ET Nucs AI and Segmed Partner to Build the Data Foundation for Precision Oncology

, Inc. streamlines access to diverse, high-quality real-world data, including medical imaging and clinical records, for biopharmaceutical R&D, AI development, and medical device innovation. With a global network of healthcare partners across five continents, Segmed provides researchers with

More news about: Nucs AI


Jul 14, 2026, 08:36 ET Brave Healer Productions Releases Brave Families: The Ultimate Guide to Long-Lasting Relationships

Brigette M. Burton, Chris Bystriansky, Sherman Daley, Ilene Dillon, Susan L. Ernst, Maria Feider, Norman Gordon, Kristina Heagh-Avritt, Sara Jane, Elizabeth R Kipp, LeEtta Klink, Sandy Krzyzanowski, Kathy Kwiatkowski, Molly McMillan, Kathleen Mitchell, Heather Potvin, Julie Schindler, Nancy Stevens, Sensei Timothy

More news about: Brave Healer Productions


Jul 14, 2026, 08:36 ET Skyhawk Therapeutics Announces Expansion of its Global Pivotal FALCON-HD Clinical Trial for SKY-0515 in Huntington's Disease to the United States, Canada and the United Kingdom

enrolling patients in our pivotal trial for Huntington's in the United States, the United Kingdom and Canada," said Sergey Paushkin, head of Skyhawk R&D. "Clinician and Patient assessments done at twelve months of treatment support what the SKY-0515's compelling and consistent effects on critical biomarkers

More news about: Skyhawk Therapeutics


Jul 14, 2026, 08:31 ET TiaLinx Appoints Retired Space Force Architect Maj. Gen. Clinton E. Crosier to Advisory Board

acceptance and early employment of the Geosynchronous Space Situational Awareness Program (GSSAP). As Director of Requirements for the U.S. Air Force (HAF/A5R), he led the development and approval of the original requirements for the SILENT BARKER program—two of the most consequential SDA capabilities fielded

More news about: TiaLinx, Inc.


Jul 14, 2026, 08:30 ET Superb AI Wins Global Vision AI Challenge at CVPR 2026

In recognition of these achievements, Superb AI was selected in December 2022 as the top-performing company in the Seoul Metropolitan Government's R&D program based on its patent registration record.Superb AI offers Superb Platform, a high-performance AI development platform that supports

More news about: Superb AI, Inc.


Jul 14, 2026, 08:17 ET Skyhawk Therapeutics Announces Expansion of its Global Pivotal FALCON-HD Clinical Trial for SKY-0515 in Huntington's Disease to the United States, Canada and the United Kingdom

enrolling patients in our pivotal trial for Huntington's in the United States, the United Kingdom and Canada," said Sergey Paushkin, head of Skyhawk R&D. "Clinician and Patient assessments done at twelve months of treatment support what the SKY-0515's compelling and consistent effects on critical biomarkers

More news about: Skyhawk Therapeutics


Jul 14, 2026, 08:12 ET MDT Introduces HFM2905 High-Frequency Magnetic Field Probe for Real-Time Magnetic Signal Analysis

bandwidth, analog output, and integrated signal conditioning in a compact USB-powered instrument, it provides an ideal measurement solution for electronics R&D, laboratory research, and industrial testing.

More news about: MultiDimension Technology Co., Ltd.


Jul 14, 2026, 08:07 ET Always Brings Fibroid Education to ESSENCE Festival of Culture to Advance Menstrual Health Awareness

Founder of The Fibroid FoundationDr. Veronica Gillispie-Bell, MD, MASAlexzandra Spatholt, Director of Feminine Care R&D, P&GAngel Beasley, Executive Director of Merchandising-Health & Wellness, CVS HealthAdditional Onsite Activations

More news about: Procter and Gamble (P&G)


Jul 14, 2026, 08:05 ET SkinMedica® Deepens Commitment to Regenerative Science with Continued Investment in Research and Development

patients."State-of-the-Art R&D FacilityThe advisory board reinforces Allergan Aesthetics' leadership in professional-grade skincare and complements its continued investment in SkinMedica innovation, including the recent expansion of the SkinMedica R&D lab in Irvine, Calif.The

More news about: AbbVie


Jul 14, 2026, 08:00 ET Sumitomo Corporation Invests in U.S.-Based GreenTek Solutions and Enters the IT Equipment Reuse and Recycling Business

https://www.sumitomocorp.com.* Major Certifications: R2v3, NAID AAA, ISO 9001, ISO 14001, ISO 27001, ISO 45001

More news about: Sumitomo Corporation of Americas


Jul 14, 2026, 08:00 ET Acurx Pharmaceuticals Announces Scientific Poster Presentation of Ibezapolstat's Microbiome Preservation Data in Multiply-recurrent C. difficile Infection

Gram-positive specific bacterial enzyme DNA polymerase IIIC (pol IIIC), inhibiting DNA replication and leading to Gram-positive bacterial cell death. Its R&D pipeline includes antibiotic product candidates that target Gram-positive bacteria, including Clostridioides difficile, methicillin- resistant

More news about: Acurx Pharmaceuticals, Inc.


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.